Harvesting the Seeds from Funding Type 1 Diabetes Research

Elizabeth Robertson and Rachel Connor on immunotherapies, screening and the next era of type 1 diabetes research

Watch the full video on YouTube.

In this episode, Elizabeth Robertson (Diabetes UK) and Rachel Connor (Breakthrough T1D) discuss one of the most exciting developments in diabetes research: the growing possibility of delaying and ultimately preventing type 1 diabetes.

Topics discussed include:

• The rapid progress of immunotherapies for type 1 diabetes
• Why early screening is becoming increasingly important
• The ELSA study and identifying people at risk before clinical diagnosis
• Stem cell-derived beta cell therapies and the latest clinical trials
• How charities accelerate research through funding and international collaboration
• The importance of ensuring new therapies reach people through healthcare systems and policy

For more content from previous episodes, visit our podcast archive.